LU81293A1 - Composant posologique pharmaceutique a liberation maitrisee - Google Patents

Composant posologique pharmaceutique a liberation maitrisee

Info

Publication number
LU81293A1
LU81293A1 LU81293A LU81293A LU81293A1 LU 81293 A1 LU81293 A1 LU 81293A1 LU 81293 A LU81293 A LU 81293A LU 81293 A LU81293 A LU 81293A LU 81293 A1 LU81293 A1 LU 81293A1
Authority
LU
Luxembourg
Prior art keywords
controlled
pharmaceutical dosage
release pharmaceutical
dosage component
component
Prior art date
Application number
LU81293A
Other languages
English (en)
French (fr)
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of LU81293A1 publication Critical patent/LU81293A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU81293A 1978-05-18 1979-05-18 Composant posologique pharmaceutique a liberation maitrisee LU81293A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/907,036 US4153677A (en) 1978-05-18 1978-05-18 Controlled-release composition

Publications (1)

Publication Number Publication Date
LU81293A1 true LU81293A1 (fr) 1979-12-07

Family

ID=25423420

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81293A LU81293A1 (fr) 1978-05-18 1979-05-18 Composant posologique pharmaceutique a liberation maitrisee

Country Status (15)

Country Link
US (1) US4153677A (nl)
JP (1) JPS54160712A (nl)
AU (1) AU525125B2 (nl)
BE (1) BE876306A (nl)
CA (1) CA1123737A (nl)
CH (1) CH640133A5 (nl)
DE (1) DE2920254A1 (nl)
DK (1) DK203879A (nl)
FR (1) FR2425853A1 (nl)
GB (1) GB2020973B (nl)
IT (1) IT1114247B (nl)
LU (1) LU81293A1 (nl)
NL (1) NL7903725A (nl)
NZ (1) NZ190394A (nl)
SE (1) SE7904353L (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4847302A (en) * 1984-06-04 1989-07-11 Merck & Co., Inc. Use of certain compounds in livestock food as growth promotants for better feed utilization and improved carcass composition
IT1176853B (it) * 1984-10-02 1987-08-18 Eurand Spa Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
CA1266235A (en) * 1985-03-25 1990-02-27 Wallace E. Becker Tablet composition for drug combinations
US4761421A (en) * 1985-05-08 1988-08-02 Merck & Co., Inc. Use of certain compounds in livestock food as growth promotants for better feed utilization and improved carcass composition
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
US6812233B1 (en) * 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
CA2067975C (en) * 1991-05-20 2003-01-14 Cynthia M. Blase Buffered matrix aspirin tablet
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
WO2005074895A1 (en) * 2004-02-04 2005-08-18 Alembic Limited Extended release coated microtablets of venlafaxine hydrochloride

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
FR5788M (nl) * 1965-11-18 1968-03-18
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
US3904671A (en) * 1969-04-01 1975-09-09 Sterling Drug Inc Esters of 3-(hydroxy or hydroxymethyl)-4-hydroxyphenyl aminomethyl ketones
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US3632739A (en) * 1969-12-29 1972-01-04 Sandoz Ag Solid sustained release pharmaceutical preparation
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition

Also Published As

Publication number Publication date
IT7922743A0 (it) 1979-05-17
FR2425853A1 (fr) 1979-12-14
AU525125B2 (en) 1982-10-21
GB2020973B (en) 1982-12-15
IT1114247B (it) 1986-01-27
JPS54160712A (en) 1979-12-19
CH640133A5 (fr) 1983-12-30
CA1123737A (en) 1982-05-18
NL7903725A (nl) 1979-11-20
NZ190394A (en) 1980-11-28
DE2920254A1 (de) 1979-11-22
DK203879A (da) 1979-11-19
US4153677A (en) 1979-05-08
GB2020973A (en) 1979-11-28
AU4695879A (en) 1979-11-22
SE7904353L (sv) 1979-11-19
BE876306A (fr) 1979-11-19

Similar Documents

Publication Publication Date Title
BE859288A (fr) Composition pharmaceutique a liberation etalee
BE879918A (fr) Distributeur de medicament
ATE22007T1 (de) Pharmazeutische mischung.
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
PT73686A (pt) Pharmaceutical formulation
AT369337B (de) Tablettenspender
DK524080A (da) Farmaceutiske midler indeholdende et kortikosteroidt stof
FR2350102A1 (fr) Composition pharmaceutique analgesique
JPS55147223A (en) Pharmaceutical medicine
DK345682A (da) Pharmaceutiske expienser
LU81293A1 (fr) Composant posologique pharmaceutique a liberation maitrisee
BE894376A (fr) Preparation pharmaceutique
BE876561A (fr) Composition pharmaceutique a base de triglycerides et de carnitine et son utilisation
GB2020655B (en) Pharmaceutical compounds
ZA787000B (en) Pharmaceutical formulation
SE7906078L (sv) Maskin for tillslutning av operkulatkapslar
FI790404A (fi) Farmaceutiska sammansaettningar
IT7950715A0 (it) Composizioni farmaceutiche a basedi ariltrifluotoetanolo
IT8019430A0 (it) Formulazione farmaceutica a cessione protratta.
DK148196C (da) Doseringsanlaeg
DK44379A (da) Punrinderivater fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser
BE867040A (fr) Composition pharmaceutique contenant un nitro-imidazole
BE891013A (fr) Compositions pharmaceutique
BE890817A (fr) Medicaments pschycotropes
FI830245L (fi) Foerbaettringar beroerande via naesan intagbara farmaceutiska kompositioner